Chemed Stock Income Statements

Chemed Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Operating Profit

Net Income

Chemed Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2018-03-31	2017-06-30	2016-06-30	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2008-09-30	2008-03-31

service revenues and sales	618,798,000	646,943,000	639,993,000	606,181,000	595,880,000	589,233,000	585,912,000	564,532,000	553,816,000	560,157,000	546,654,000	526,472,000	531,288,000	530,549,000	540,978,000	538,667,000	532,256,000	527,360,000	533,289,000	528,297,000	502,199,000	515,798,000	522,324,000	480,613,000	473,584,000	439,176,000	415,059,000	278,739,000	386,226,000	381,921,000	376,652,000	358,389,000	360,182,000	358,300,000	340,886,000	357,198,000	366,641,000	354,353,000	354,170,000	341,439,000	333,360,000	330,918,000	320,451,000	314,995,000	308,813,000	296,794,000	288,312,000	285,268,000
yoy	3.85%	9.79%	9.23%	7.38%	7.60%	5.19%	7.18%	7.23%	4.24%	5.58%	1.05%	-2.26%	-0.18%	0.60%	1.44%	1.96%	5.99%	2.24%	2.10%	9.92%	6.04%	17.45%	25.84%	72.42%	22.62%	14.99%	10.20%	-22.22%	7.23%	6.59%	10.49%	0.33%	-1.76%	1.11%	-3.75%	4.62%	9.98%	7.08%	10.52%	8.40%	7.95%	11.50%	11.15%	10.42%
qoq	-4.35%	1.09%	5.58%	1.73%	1.13%	0.57%	3.79%	1.93%	-1.13%	2.47%	3.83%	-0.91%	0.14%	-1.93%	0.43%	1.20%	0.93%	-1.11%	0.94%	5.20%	-2.64%	-1.25%	8.68%	1.48%	7.83%	5.81%	48.91%	-27.83%	1.13%	1.40%	5.10%	-0.50%	0.53%	5.11%	-4.57%	-2.58%	3.47%	0.05%	3.73%	2.42%	0.74%	3.27%	1.73%	2.00%	4.05%	2.94%	1.07%
cost of services provided and goods sold	434,105,000	430,530,000	405,875,000	396,187,000	389,750,000	385,127,000	358,346,000	362,358,000	374,193,000	370,705,000	349,570,000	346,934,000	336,821,000	336,552,000	336,328,000	342,164,000	350,493,000	340,473,000	335,049,000	339,240,000	352,163,000	351,745,000	347,355,000	328,183,000	323,637,000	304,536,000	285,852,000	218,694,000	272,089,000	270,663,000	268,885,000	256,445,000	257,007,000	257,819,000	243,184,000	255,359,000	264,307,000	256,610,000	257,368,000	245,063,000	239,597,000	237,458,000	227,915,000	223,702,000	219,137,000	208,888,000
selling, general and administrative expenses	100,323,000	105,587,000	104,251,000	101,981,000	102,255,000	115,873,000	100,436,000	99,602,000	94,987,000	100,095,000	96,928,000	83,992,000	87,853,000	89,954,000	92,073,000	89,217,000	93,838,000	91,599,000	86,805,000	88,317,000	84,513,000	70,583,000	83,291,000	76,836,000	71,556,000	69,000,000	68,654,000	22,638,000	55,197,000	57,994,000	58,588,000	53,566,000	53,649,000	55,671,000	48,870,000	53,107,000	55,560,000	52,955,000	49,770,000	47,618,000	50,424,000	55,654,000	48,200,000	49,956,000	48,538,000	48,148,000	44,022,000	42,727,000
depreciation	13,689,000	13,445,000	13,263,000	13,147,000	13,167,000	13,287,000	13,024,000	12,858,000	12,634,000	12,286,000	12,096,000	12,154,000	12,714,000	12,138,000	11,840,000	11,844,000	13,612,000	11,715,000	11,835,000	11,714,000	11,659,000	11,388,000	11,126,000	10,147,000	9,887,000	9,267,000	8,833,000	4,814,000	8,075,000	8,082,000	8,032,000	7,450,000	7,272,000	7,149,000	6,971,000	6,899,000	6,795,000	6,557,000	6,380,000	6,313,000	6,358,000	6,288,000	6,385,000	6,194,000	5,469,000	5,361,000	5,441,000	5,438,000
amortization	2,571,000	2,572,000	2,568,000	2,550,000	2,546,000	2,521,000	2,515,000	2,521,000	2,514,000	2,513,000	2,512,000	2,520,000	2,520,000	2,518,000	2,510,000	2,510,000	2,510,000	2,510,000	2,511,000	2,511,000	2,488,000	2,477,000	2,969,000	441,000	406,000	27,000	32,000	14,000	737,000	582,000	576,000	717,000	735,000	1,009,000	1,190,000	1,181,000	1,127,000	1,135,000	1,127,000	1,134,000	1,139,000	970,000	1,196,000	1,287,000	1,224,000	1,611,000	1,494,000	1,450,000
other operating expense	26,000	51,000	72,000	159,000		92,000				1,739,000
total costs and expenses	550,714,000	552,185,000	526,115,000	514,024,000	507,755,000	516,900,000	474,518,000	477,682,000	484,310,000	487,338,000	465,327,000	445,615,000	439,350,000	441,175,000	442,949,000	445,798,000	460,557,000	446,919,000	390,040,000	453,989,000	409,439,000	436,435,000	444,872,000	415,685,000	408,056,000	382,779,000	454,007,000	250,651,000	336,098,000	337,321,000	336,081,000	318,178,000	318,663,000	321,648,000	311,676,000	331,306,000	327,789,000	318,383,000	314,645,000	300,128,000	297,518,000	300,370,000	283,696,000	281,139,000	274,368,000	264,008,000	253,403,000	255,427,000
income from operations	68,084,000	94,758,000	113,878,000	92,157,000	88,125,000	72,333,000	111,394,000	86,850,000	69,506,000	72,819,000	81,327,000	80,857,000	91,938,000	89,374,000	98,029,000	92,869,000	71,699,000	80,441,000	143,249,000	74,308,000	92,760,000	79,363,000	77,452,000	64,928,000	65,528,000	56,397,000			50,128,000	44,600,000	40,571,000	40,211,000	41,519,000	36,652,000	29,210,000	25,892,000	38,852,000	35,970,000	39,525,000	41,311,000	35,842,000	30,548,000	36,755,000	33,856,000	34,445,000	32,786,000	34,909,000	29,841,000
yoy	-22.74%	31.00%	2.23%	6.11%	26.79%	-0.67%	36.97%	7.41%	-24.40%	-18.52%	-17.04%	-12.93%	28.23%	11.11%	-31.57%	24.98%	-22.70%	1.36%	84.95%	14.45%	41.56%	40.72%			30.72%	26.45%			20.74%	21.69%	38.89%	55.30%	6.86%	1.90%	-26.10%	-37.32%	8.40%	17.75%	7.54%	22.02%	4.06%	-6.83%	5.29%	13.45%
qoq	-28.15%	-16.79%	23.57%	4.58%	21.83%	-35.07%	28.26%	24.95%	-4.55%	-10.46%	0.58%	-12.05%	2.87%	-8.83%	5.56%	29.53%	-10.87%	-43.85%	92.78%	-19.89%	16.88%	2.47%	19.29%	-0.92%	16.19%				12.39%	9.93%	0.90%	-3.15%	13.28%	25.48%	12.81%	-33.36%	8.01%	-8.99%	-4.32%	15.26%	17.33%	-16.89%	8.56%	-1.71%	5.06%	-6.08%	16.98%
operating margin %	11.00%	14.65%	17.79%	15.20%	14.79%	12.28%	19.01%	15.38%	12.55%	13.00%	14.88%	15.36%	17.30%	16.85%	18.12%	17.24%	13.47%	15.25%	26.86%	14.07%	18.47%	15.39%	14.83%	13.51%	13.84%	12.84%	0%	0%	12.98%	11.68%	10.77%	11.22%	11.53%	10.23%	8.57%	7.25%	10.60%	10.15%	11.16%	12.10%	10.75%	9.23%	11.47%	10.75%	11.15%	11.05%	12.11%	10.46%
interest expense	-443,000	-329,000	-499,000	-427,000	-429,000	-425,000	-342,000	-444,000	-771,000	-1,551,000	-1,601,000	-1,271,000	-902,000	-810,000	-525,000	-583,000	-379,000	-381,000	-350,000	-379,000	-651,000	-975,000	-1,133,000	-1,041,000	-1,237,000	-1,207,000	-1,121,000	-59,000	-908,000	-969,000	-969,000	-980,000	-2,429,000	-3,815,000	-3,500,000	-3,697,000	-4,094,000	-3,743,000	-3,672,000	-3,555,000	-3,461,000	-3,244,000	-2,995,000	-2,999,000	-2,952,000	-2,853,000	-1,570,000	-1,597,000
other income - net	3,474,000	1,245,000	7,002,000	9,299,000	6,132,000					-103,000					2,630,250	3,134,000			1,430,750	7,675,000			1,372,000	3,036,000	13,000	1,018,000				536,000	563,000	705,000	756,000	816,000		1,696,000	1,706,000				714,000
income before income taxes	71,115,000	95,674,000	120,123,000	101,029,000	93,828,000	84,485,000	115,593,000	93,265,000	70,344,000	71,165,000	82,400,000	76,471,000	86,106,000	84,702,000	96,127,000	95,420,000	75,105,000	83,662,000	145,841,000	81,604,000	99,623,000	68,922,000	79,595,000	66,923,000	64,304,000	56,208,000			46,865,000	44,167,000	40,165,000	39,936,000	39,846,000	33,653,000	25,620,000	23,891,000	36,464,000	34,067,000	34,883,000	35,821,000	33,095,000	29,406,000	33,982,000	30,867,000	31,679,000	31,666,000	31,431,000	27,055,000
income taxes	-18,622,000	-23,917,000	-29,804,000	-25,253,000	-22,941,000	-19,468,000	-25,540,000	-18,307,000	-16,967,000	-17,044,000	-20,274,000	-19,598,000	-19,650,000	-20,533,000	-21,502,000	-23,417,000	-18,583,000	-18,262,000	-32,089,000	-13,882,000	-17,522,000	-13,031,000	-14,015,000	-7,976,000	-13,575,000	-11,212,000	16,760,000	-11,444,000	-18,032,000	-17,192,000	-15,628,000	-15,351,000	-15,483,000	-13,079,000	-8,188,000	-9,283,000	-14,186,000	-13,222,000	-13,609,000	-13,934,000	-12,809,000	-11,305,000	-12,994,000	-12,012,000	-12,321,000	-12,456,000	-13,483,000	-10,235,000
net income	52,493,000	71,757,000	90,319,000	75,776,000	70,887,000	65,017,000	90,053,000	74,958,000	53,377,000	54,121,000	62,126,000	56,873,000	66,456,000	64,169,000	74,625,000	72,003,000	56,522,000	65,400,000	113,752,000	67,722,000	82,101,000	55,891,000	65,580,000	58,947,000	50,729,000	44,996,000		1.48	28,833,000	26,975,000	24,537,000	24,585,000	24,363,000	20,574,000	17,432,000	14,608,000	22,278,000	20,845,000	21,274,000	21,887,000	20,286,000	18,101,000	20,988,000	18,855,000	19,358,000	19,210,000	17,948,000	16,820,000
yoy	-25.95%	10.37%	0.30%	1.09%	32.80%	20.13%	44.95%	31.80%	-19.68%	-15.66%	-16.75%	-21.01%	17.58%	-1.88%	-34.40%	6.32%	-31.16%	17.01%	73.46%	14.89%	61.84%	24.21%		3982905305.41%	75.94%	66.81%		-100.00%	18.35%	31.11%	40.76%	68.30%	9.36%	-1.30%	-18.06%	-33.26%	9.82%	15.16%	1.36%	16.08%	4.79%	-5.77%	16.94%	12.10%
qoq	-26.85%	-20.55%	19.19%	6.90%	9.03%	-27.80%	20.14%	40.43%	-1.37%	-12.89%	9.24%	-14.42%	3.56%	-14.01%	3.64%	27.39%	-13.57%	-42.51%	67.97%	-17.51%	46.89%	-14.77%	11.25%	16.20%	12.74%			-100.00%	6.89%	9.94%	-0.20%	0.91%	18.42%	18.02%	19.33%	-34.43%	6.87%	-2.02%	-2.80%	7.89%	12.07%	-13.76%	11.31%	-2.60%	0.77%	7.03%	6.71%
net income margin %	8.48%	11.09%	14.11%	12.50%	11.90%	11.03%	15.37%	13.28%	9.64%	9.66%	11.36%	10.80%	12.51%	12.09%	13.79%	13.37%	10.62%	12.40%	21.33%	12.82%	16.35%	10.84%	12.56%	12.26%	10.71%	10.25%	0%	0.00%	7.47%	7.06%	6.51%	6.86%	6.76%	5.74%	5.11%	4.09%	6.08%	5.88%	6.01%	6.41%	6.09%	5.47%	6.55%	5.99%	6.27%	6.47%	6.23%	5.90%
earnings per share:
average number of shares outstanding	14,591	14,622	-58	15,025	15,097	15,121	16	15,075	15,058	14,966	-6	14,888	14,932	14,986	-137	15,587	15,829	16,010	7	15,940	15,914	15,991	17	15,970	15,928	16,100	16,010	16,831	16,865	16,880	16,914	17,039	17,236	17,510	18,184	18,606	18,522	18,960	18,998	20,674	21,115	21,055	22,597	22,644	22,593	22,461		23,873
diluted earnings per share:
cash dividends per share	0.5	0.5	0.325	0.5	0.4	0.4	0.29	0.4	0.38	0.38	0.275	0.38	0.36	0.36	0.26	0.36	0.34	0.34	0.245	0.34	0.32	0.32	0.23	0.32	0.3	0.28	0.26		0.24	0.22	0.22	0.22	0.2	0.2	0.2	0.18	0.18	0.18	0.16	0.16	0.14	0.14	0.14	0.12	0.12	0.12	0.06	0.06
see accompanying notes to unaudited consolidated financial statements.
other operating expense/					37,000		516,000	343,000	-18,000		-132,500	15,000
other income/(expense) - net						12,577,000	2,091,250	6,859,000									3,785,000	3,602,000									1,653,000		-2,355,000						-90,000			1,840,000	-970,000	-1,935,000
other income/(income) - net									1,609,000
other (expense)/income - net											-2,976,750	-3,115,000	-4,930,000	-3,862,000							7,514,000	-9,466,000
other operating (income)/expense													-558,000
other operating expenses														13,000				622,000				242,000	131,000	78,000			90,636,000	4,491,000							11,461,000	14,760,000		1,126,000
other operating expenses/															197,250	63,000	104,000								2,570,000	-51,000
other operating (income)/expenses																			-7,233,750	12,207,000	-41,384,000
income/(loss) from operations																											-38,948,000	28,088,000
income/(loss) before income taxes																											-38,416,000
net income/																											-21,656,000	18,550,000
earnings/(loss) per share
diluted earnings/(loss) per share
sg&a expenses before market value adjustments of deferred compensation
plans, long-term incentive compensation, and oig investigation expenses																												117,708,000
long-term incentive compensation																												258,000
expenses related to oig investigation																												3,506,000
impact of market value adjustments related to assets held in deferred
compensation trusts																												201,000
total sg&a expenses																												121,673,000
market value adjustment on assets held in
deferred compensation trusts																												201,000
loss on disposal of property and equipment																												-90,000
interest income - net																												182,000
other																												6.2
total other income/(expense) - net																												293,000
vitas																												-3,479,000
legal expenses of oig investigation																												-2,165,000
early retirement expenses																												-2,840,000
roto-rooter																												2,198,000
expenses related to litigation settlements																												-27,000
acquisition expenses
corporate																												-506,000
stock option expense																												-3,061,000
expenses of securities litigation
total																												-8,257,000
chemed corporation and subsidiary companies
consolidating statement of income
for the three months ended june 30, 2016
2016
intercompany interest income/																												1,927,000
other income/(expense)—net																												38,000
income/(expense) before income taxes																												29,994,000
pretax benefit/
expenses related to securities litigation
after-tax benefit/
for the three months ended june 30, 2015
2015
for the six months ended june 30, 2016
for the six months ended june 30, 2015
unaudited consolidating summary and reconciliation of adjusted ebitda
add/
ebitda																												34,881,000
intercompany interest expense/																												-1,927,000
interest income																												-69,000
amortization of stock awards																												85,000
advertising cost adjustment
adjusted ebitda																												38,631,000
stock award amortization																												216,000
reconciliation of adjusted net income
net income as reported																												24,885,000
add/(deduct) after-tax cost of:
expenses of oig investigation																												722,000
expenses related to securities settlements																												-2,000
adjusted net income																												30,228,000
diluted earnings per share as reported
adjusted diluted earnings per share
adjusted average number of shares outstanding																												16,831
operating statistics for vitas segment
operating statistics																												2,016
net revenue
homecare																												219,280
inpatient																												24,489
continuous care																												34,970
total before medicare cap allowance																												278,739
medicare cap allowance
net revenue as a percent of total before medicare cap allowances
average daily census
nursing home																												3,015
routine homecare																												15,022
total admissions																												16,180
total discharges																												15,960
average length of stay																												84.2
median length of stay																												16
adc by major diagnosis
cerebro																												31.9
neurological																												21.3
cancer																												15.2
cardio																												17.6
respiratory																												7.8
admissions by major diagnosis
direct patient care margins
homecare margin drivers
labor costs																												56.29
combined drug, hme and medical supplies																												15.92
inpatient margin drivers
continuous care margin drivers
bad debt expense as a percent of revenues																												1.2
accounts receivable -- days of revenue outstanding- excluding unapplied medicare payments																												37.7
accounts receivable -- days of revenue outstanding- including unapplied medicare payments																												26.6
february 2011 program
january 1 through january 31, 2016
february 1 through february 29, 2016																												153,997
march 1 through march 31, 2016																												246,003
first quarter total																												400,000
april 1 through april 30, 2016
may 31 through may 31, 2016																												93,607
june 1 through june 30, 2016																												286,527
second quarter total																												380,134
on march 14, 2016 our board of directors authorized an additional 100 million under the february 2011 repurchase program.
exhibit no.
31.1
31.2
31.3
32.1
32.2
32.3
101.ins
101.sch
101.cal
101.def
101.lab
101.pre
dated:
earnings per share
diluted earnings per share
see accompanying notes to unaudited financial statements.
other income																																										2,102,000
other income--net																																											222,000	10,000
other income/(expense)--net																																													186,000	1,733,000
continuing operations
other operating income
loss on extinguishment of debt
other (expense)/income--net																																															-1,908,000	-1,189,000
income from continuing operations																																															17,948,000
discontinued operations, net of income taxes
average number of share outstanding																																															22,503

We provide you with 20 years income statements for Chemed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Chemed stock. Explore the full financial landscape of Chemed stock with our expertly curated income statements.

The information provided in this report about Chemed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.